Ireland
--:--IST
Latest
Clinical Trials in Denmark / NCT06723639
Recruiting Not applicable

Restoring Anatomy of Ruptured Achilles Tendon

NCT06723639 · tracked via the Priya Life Science Denmark tracker
Phase
Not applicable
Started
2025-02-28
Last updated
2025-04-15

Condition(s) studied

Achilles Tendon Rupture

Investigational drug(s) / intervention(s)

A new two-layer surgical techniqueStandard non-surgical treatment

A new two-layer surgical technique: A new double row suturing technique attempting to restore the length of the distinct soleus and gastrocnemius portions of the Achilles tendon.

Standard non-surgical treatment: Standard non-surgical treatment

Study summary

The goal of this clinical trial is to investigate a new surgical approach to restore the anatomy of a ruptured Achilles tendon. We will use a new two-layer technique followed by rehabilitation and find out how it influence the patients clinical outcome, muscle and tendon structure, and function after one year and compare with a standard non-surgical approach followed by rehabilitation. Participants will be randomized to 1) NEWSUR: A new two-layer surgical technique followed by rehabilitation regime or 2) CONSER: A standard non-surgical treatment followed by rehabilitation .

We hypothesize that restoring the anatomy of the ruptured mid-substance Achilles tendon using a new two-layer surgery technique followed by rehabilitation will yield a more favorable patient reported outcome (ATRS) one year after rupture compared to standard non-surgical treatment followed by rehabilitation.

Eligibility

Sex
ALL
Min age
18 Years
Max age
67 Years
Healthy volunteers
No
Inclusion Criteria: * Diagnosed with a complete mid-substance Achilles tendon rupture based on clinical exam, including Thompson/Matles test, by an experienced physician. * Presented within 14 days from injury. * Understands and reads Danish. * No contraindications for MRI. Exclusion Criteria: * Smoking * Diabetes * Other injuries affecting their lower limb function. * Contralateral Achilles tendon rupture. * Re-rupture. * Anticoagulation treatment. * Inability to follow rehabilitation or complete follow-up tests. * Immunosuppressive treatment, including systemic corticosteroid treatment. * Pregnant

Primary outcome measure(s)

Trial sites (3)

FacilityCityRegionStatus
, Copenhagen University Hospital Bispebjerg-Frederiksberg Hospital, Copenhagen, Denmark. Copenhagen Capital Recruiting
Copenhagen University Hospital, Amager-Hvidovre Copenhagen Capital Not Yet Recruiting
Sahlgrenska University Hospital Gothenburg Sweden Not Yet Recruiting

More Bispebjerg Hospital trials in Denmark

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT06723639 on ClinicalTrials.gov ↗ ← All trials in Denmark